Account
Zenith wins media account of Bombay Dyeing
MUMBAI: Zenith has bagged the full range of media duties, including of digital and social of home furnishing brand, Bombay Dyeing. Bombay Dyeing is part of the Wadia Group of Companies established in 1879 and is among the oldest and most respected business houses across the country
Zenith group CEO Tanmay Mohanty says, “Bombay Dyeing needs no introduction. It is more than a century-old brand, and one that has stood the test of time and successfully maintained the lead. They have experimented and innovated and stayed ahead of the curve. It is a great opportunity for us to put forward our strategic thinking, integrated solutions and drive on ROI for Bombay Dyeing’s investments. India’s retail industry is poised for significant growth and consumer sentiment is buoyant. It is an opportune timing to be partnering with them.”
Bombay Dyeing marketing head Michael Nadar says, “We were looking for an agency that scores on both ambition and agility. An agency that gives quick turnaround and can pre-empt the changes ahead. Zenith understands the pulse of Indian consumers. Their passion for the job, innovative thinking and strong play in consumer insights, digital, technology, content and analytics makes them the right partner for us. We look forward to a long and fulfilling partnership with them.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
